First-String Research

First-String Research is an innovative biopharmaceutical company dedicated to discovering breakthrough therapies based on inflammation and injury. The company focuses on developing and bringing to market new therapeutic products that enable physicians to address unmet medical needs. Its treatment methods aim to resolve these conditions by reducing excessive inflammation, calming inflamed tissues, and restarting the body’s normal injury response mechanisms, thereby facilitating the healing process. The management team of First-String Research has a strong track record of establishing and leading companies in research, biotechnology, and biopharmaceutical sectors, bringing decades of experience in drug discovery and development. The company’s scientific excellence and extensive expertise throughout the drug discovery and development process have led to FDA-approved breakthrough treatments in oncology and inflammatory diseases.